Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Periventricular lesions help differentiate neuromyelitis optica spectrum disorders from multiple sclerosis.
The effects of massage therapy on multiple sclerosis patients' quality of life and leg function.
Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.
Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.
SMC Says Yes to Lemtrada(R)a- 1/4 (alemtuzumab) 12mg IV, a New Treatment for Adults with Active Relapsing Remitting-Multiple Sclerosis (RRMS)
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
[Epidemiology of multiple sclerosis in the Primosky Krai and Far East regions.]
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update.
An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™ (PERSIST)
Santhera enters agreement with Columbia University to investigate additional potential of Catena® in MELAS
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial.
Amiloride HCI Tablets, USP 5 mg
Focused suggestion with somatic anchoring technique: rapid self-hypnosis for pain management.
Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis.
Self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis following interdisciplinary rehabilitation.
FDA approves Ampyra to improve walking in adults with multiple sclerosis
Food and Drug Administration briefing document for ofatumumab
Anejaculatory infertility due to multiple sclerosis.
Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.

Pages